These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7386491)

  • 21. Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia.
    Schwartz A; Shen E; Morady F; Gillespie K; Scheinman M; Chatterjee K
    Am Heart J; 1983 Oct; 106(4 Pt 2):848-56. PubMed ID: 6613831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hemodynamic effects of disopyramide on postischemic and normal myocardium].
    Hoffmeister HM; Hörmann HP; Beyer M; Seipel L
    Klin Wochenschr; 1990 Dec; 68(23):1178-82. PubMed ID: 2280581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic effects of penticainide (CM 7857), a novel class I antiarrhythmic drug--comparison with disopyramide.
    Pfisterer M; Munoz A; Burkart F
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):247-51. PubMed ID: 2459557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse hemodynamic effects of intravenous disopyramide compared with quinidine in conscious dogs.
    Walsh RA; Horwitz LD
    Circulation; 1979 Nov; 60(5):1053-8. PubMed ID: 487539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous disopyramide in acute myocardial infarction: a haemodynamic and pharmacokinetic study.
    Cameron J; Stafford W; Pritchard D; Norris R; Ravenscroft P
    J Cardiovasc Pharmacol; 1984; 6(1):126-31. PubMed ID: 6199595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemodynamics of intravenous disopyramide.
    Sutton R
    J Int Med Res; 1976; 4(1 Suppl):46-8. PubMed ID: 1026528
    [No Abstract]   [Full Text] [Related]  

  • 27. Kinetics of hemodynamic and electrocardiographic changes following intravenous disopyramide.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1979; 205(5):417-23. PubMed ID: 443082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative haemodynamic effects of intravenous lignocaine, disopyramide and flecainide in uncomplicated acute myocardial infarction.
    Silke B; Frais MA; Verma SP; Reynolds GW; Hafizullah M; Kalra PA; Jackson NC; Taylor SH
    Br J Clin Pharmacol; 1986 Dec; 22(6):707-14. PubMed ID: 3105568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiological effects of disopyramide phosphate during experimental myocardial ischemia.
    Levites R; Anderson GJ
    Am Heart J; 1979 Sep; 98(3):339-44. PubMed ID: 474380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs.
    Kleinert HD; Volpe M; Odell G; Marion D; Atlas SA; Camargo MJ; Laragh JH; Maack T
    Hypertension; 1986 Apr; 8(4):312-6. PubMed ID: 2937724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
    G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of the acute electrophysiological and cardiovascular action of disopyramide in man.
    Marrott PK; Ruttley MS; Winterbottam JT; Muir JR
    Eur J Cardiol; 1976 Sep; 4(3):303-12. PubMed ID: 964279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction.
    Kus T; Sasyniuk BI
    J Pharmacol Exp Ther; 1976 Mar; 196(3):665-75. PubMed ID: 1263118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute hemodynamic effects of intravenous encainide in patients with heart disease.
    Tucker CR; Winkle RA; Peters FA; Harrison DC
    Am Heart J; 1982 Aug; 104(2 Pt 1):209-15. PubMed ID: 6808816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation.
    Bennett DH
    Chest; 1978 Dec; 74(6):624-8. PubMed ID: 738119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
    Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
    Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiologic effects of disopyramide phosphate on sinus node function in patients with sinus node dysfunction.
    LaBarre A; Strauss HC; Scheinman MM; Evans GT; Bashore T; Tiedeman JS; Wallace AG
    Circulation; 1979 Feb; 59(2):226-35. PubMed ID: 758990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate.
    Befeler B; Castellanos A; Wells DE; Vagueiro MC; Yeh BK
    Am J Cardiol; 1975 Feb; 35(2):282-7. PubMed ID: 1119389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.